Theravance Biopharma Inc Net Asset Momentum
Theravance Biopharma Inc net asset momentum. Theravance Biopharma Inc (TBPH) recorded a net asset momentum of 69.0% as of December 2025, with net assets of $296.72 Million USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore TBPH capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Theravance Biopharma Inc (2011–2025)
Net asset momentum of Theravance Biopharma Inc from 2011 to 2025. This chart tracks Theravance Biopharma Inc's year-over-year net asset growth across 15 annual reporting periods from 2011 to 2025. The most recent momentum reading is +69.0%, with net assets of $296.72 Million USD as of December 2025. See shareholders equity of Theravance Biopharma Inc for net asset value and shareholders' equity analysis.
Theravance Biopharma Inc Net Asset Momentum by Year (2011–2025)
Theravance Biopharma Inc net asset momentum by year from 2011 to 2025. The table below shows the complete annual net asset history for Theravance Biopharma Inc from 2011 to 2025, covering 15 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see how much is Theravance Biopharma Inc worth.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $296.72 Million | $485.57 Million | $188.85 Million | ▲ +69.0% |
| 2024 | $175.54 Million | $354.16 Million | $178.62 Million | ▼ -17.6% |
| 2023 | $213.00 Million | $382.00 Million | $169.00 Million | ▼ -51.8% |
| 2022 | $441.80 Million | $607.40 Million | $165.60 Million | ▲ +230.5% |
| 2021 | $-338.57 Million | $374.82 Million | $713.39 Million | ▼ -11.5% |
| 2020 | $-303.75 Million | $469.06 Million | $772.81 Million | ▼ -35.7% |
| 2019 | $-223.84 Million | $408.83 Million | $632.67 Million | ▼ -333.9% |
| 2018 | $-51.59 Million | $560.24 Million | $611.82 Million | ▼ -144.8% |
| 2017 | $115.18 Million | $441.40 Million | $326.22 Million | ▼ -67.1% |
| 2016 | $350.23 Million | $639.25 Million | $289.02 Million | ▲ +44.1% |
| 2015 | $243.06 Million | $300.12 Million | $57.05 Million | ▼ -16.1% |
| 2014 | $289.79 Million | $337.77 Million | $47.98 Million | ▲ +1801.1% |
| 2013 | $-17.04 Million | $25.18 Million | $42.21 Million | ▼ -896.2% |
| 2012 | $-1.71 Million | $20.96 Million | $22.67 Million | ▲ +98.8% |
| 2011 | $-140.72 Million | $13.82 Million | $154.54 Million | — |